Deb Hart | IR |
Carl Hull | Chairman and CEO |
Kevin Herde | CFO |
Matt Sykes | Goldman Sachs |
Tejas Savant | Morgan Stanley |
Dan Arias | Stifel |
Matt Larew | William Blair |
Michael Ryskin | Bank of America |
Ladies and gentlemen thank you for standing by and welcome to the Maravai Lifesciences Second quarter 2021 earnings conference call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions] I would like to turn the conference over to Deb Hart, Head of Investor Relations. Please go ahead.